Are we ready to predict late effects? A systematic review of clinically useful prediction models

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Talya SalzAndrew J Vickers

Abstract

After completing treatment for cancer, survivors may experience late effects: consequences of treatment that persist or arise after a latent period. To identify and describe all models that predict the risk of late effects and could be used in clinical practice. We searched Medline through April 2014. Studies describing models that (1) predicted the absolute risk of a late effect present at least 1 year post-treatment, and (2) could be used in a clinical setting. Three authors independently extracted data pertaining to patient characteristics, late effects, the prediction model and model evaluation. Across 14 studies identified for review, nine late effects were predicted: erectile dysfunction and urinary incontinence after prostate cancer; arm lymphoedema, psychological morbidity, cardiomyopathy or heart failure and cardiac event after breast cancer; swallowing dysfunction after head and neck cancer; breast cancer after Hodgkin lymphoma and thyroid cancer after childhood cancer. Of these, four late effects are persistent effects of treatment and five appear after a latent period. Two studies were externally validated. Six studies were designed to inform decisions about treatment rather than survivorship care. Nomograms were th...Continue Reading

References

May 1, 1993·Medical Care·P A GanzM L Polinsky
May 16, 2003·Current Problems in Cancer·Kevin C Oeffinger
Nov 16, 2004·International Journal of Cancer. Journal International Du Cancer·Carina NordSophie D Fosså
Oct 6, 2005·Journal of the National Cancer Institute·Lois B TravisMitchell H Gail
Sep 23, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Christine EiserHelena Davies
Feb 22, 2007·Journal of the National Cancer Institute·Tara O HendersonLisa Diller
Aug 19, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M L G Janssen-HeijnenJ W W Coebergh
Apr 22, 2008·The Journal of Urology·James A EasthamMichael W Kattan
Jan 27, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Johannes A LangendijkBen J Slotman
Apr 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maryska L G Janssen-HeijnenJan-Willem W Coebergh
Mar 1, 2007·Journal of Oncology Practice·Clese EriksonMichael Goldstein
Sep 22, 2011·JAMA : the Journal of the American Medical Association·Mehrdad AlemozaffarMartin G Sanda
Oct 8, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Leslie L Robison, Wendy Demark-Wahnefried
Oct 8, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Eva GrunfeldEllen Stovall
Mar 8, 2012·Annals of Surgical Oncology·José Luiz B BevilacquaAnke Bergmann
Nov 22, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephanie A KovalchikRuth M Pfeiffer
Dec 1, 2012·Journal of the National Cancer Institute·Joanne W ElenaAndrew N Freedman
Aug 6, 2013·Cancer·Emily C ZaborKatherine S Panageas
Oct 1, 2013·The Journal of Urology·Jonathan J ChipmanUNKNOWN PROST-QA Consortium
Mar 4, 2014·Journal of the American Heart Association·Ghideon EzazJersey Chen

❮ Previous
Next ❯

Citations

Aug 10, 2016·BMC Systems Biology·Fleur JeanquartierAndreas Holzinger
Dec 3, 2016·PloS One·Paul KotwinskiUNKNOWN Breast cancer Early disease: Toxicity from Therapy with Epirubicin Regimens–Cardiac Assessment and Risk Evaluation (BETTER-C
Jun 7, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wendy LandierMelissa M Hudson
Aug 18, 2018·American Journal of Physical Medicine & Rehabilitation·Andrea L ChevilleKathryn J Ruddy
Apr 11, 2018·Oncoimmunology·Paola CircostaGiorgio Inghirami
Jun 25, 2019·Archives of Rehabilitation Research and Clinical Translation·Isabella AlvaradoAndrea L Cheville
Jun 25, 2018·Practical Radiation Oncology·Stephen A MihalcikUNKNOWN PROST-QA Consortium

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.

Related Papers

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
M M Hassouna, J P Heaton
JAMA : the Journal of the American Medical Association
Kevin C Oeffinger, Leslie L Robison
© 2022 Meta ULC. All rights reserved